|
US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
|
EP0903344B1
(en)
*
|
1997-08-21 |
2011-01-26 |
Shiseido Co., Ltd. |
Quinazolin-4-one derivatives, their preparation and their use as hair growth promoters or in external compositions for skin
|
|
US6436919B1
(en)
|
1999-10-01 |
2002-08-20 |
Theravance Inc. |
Local anesthetic compounds
|
|
JP4642309B2
(ja)
*
|
2000-04-25 |
2011-03-02 |
イコス・コーポレイション |
ヒトホスファチジル−イノシトール３−キナーゼデルタの阻害剤
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
|
WO2003020280A2
(en)
*
|
2001-09-05 |
2003-03-13 |
Minerva Biotechnologies Corporation |
Compositions and use thereof in the treatment of cancer
|
|
ATE469648T1
(de)
|
2001-09-05 |
2010-06-15 |
Minerva Biotechnologies Corp |
Zusammensetzungen und deren verwendung zur behandlung von krebs
|
|
WO2003039460A2
(en)
*
|
2001-11-07 |
2003-05-15 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
|
WO2004018058A2
(en)
*
|
2002-08-21 |
2004-03-04 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
EP1558260A4
(en)
*
|
2002-11-04 |
2006-10-25 |
Nps Pharma Inc |
CHINAZOLINONE COMPOUNDS AS CALCILYTIC
|
|
DE602004022819D1
(de)
*
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
|
WO2005016348A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
|
WO2005016349A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methods of inhibiting leukocyte accumulation
|
|
ES2873875T3
(es)
|
2004-05-13 |
2021-11-04 |
Icos Corp |
Quinazolinonas como inhibidores de fosfatidilinositol 3-quinasa delta humano
|
|
CA2567883A1
(en)
*
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
|
CA2598409A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
WO2007110868A2
(en)
|
2006-03-28 |
2007-10-04 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
SG195655A1
(en)
|
2008-11-13 |
2013-12-30 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
|
SG174529A1
(en)
|
2009-03-24 |
2011-10-28 |
Gilead Calistoga Llc |
Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
|
US8546409B2
(en)
*
|
2009-04-20 |
2013-10-01 |
Gilead Calistoga Llc |
Methods of treatment for solid tumors
|
|
EP2456443A1
(en)
|
2009-07-21 |
2012-05-30 |
Gilead Calistoga LLC |
Treatment of liver disorders with pi3k inhibitors
|
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
|
EP3581567A1
(en)
*
|
2011-04-10 |
2019-12-18 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
WO2013134288A1
(en)
|
2012-03-05 |
2013-09-12 |
Gilead Calistoga Llc |
Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
|
|
US9359367B2
(en)
|
2012-07-09 |
2016-06-07 |
Lupin Limited |
Tetrahydroquinazolinone derivatives as PARP inhibitors
|
|
SI3083630T1
(sl)
|
2013-12-20 |
2019-11-29 |
Gilead Calistoga Llc |
Postopek sinteze inhibitorjev fosfatidilinozitol 3-kinaze
|
|
EP3083623A1
(en)
|
2013-12-20 |
2016-10-26 |
Gilead Calistoga LLC |
Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
|
|
CN106459005A
(zh)
|
2014-06-13 |
2017-02-22 |
吉利德科学公司 |
磷脂酰肌醇3‑激酶抑制剂
|